NextGenNK
NextGenNK is a Competence Center for the development of next generation NK cell-based cancer immunotherapies. The Center is coordinated by Karolinska Institutet and collaborates with the Karolinska University Hospital and prominent national and international industrial partners. The Center was launched in 2020, and is jointly funded by Vinnova, KI, and the Industrial partners.
Upcoming events NextGenNK
NextGenNK at Innate Killer Summit – 2020
NextGenNK at Innate Killer Summit – 2020
The Directors of NextGenNK presented their research and the Competence Center at the digital event - Innate Killer Summit 2020, August 24-26.
NextGenNK interacts with CAMP
NextGenNK interacts with CAMP
NextGenNK sets out to deepen its interactions with health care units. Activities, when applicable, will be integrated with the Vinnova funded CAMP, that focuses specifically on GMP-bioprocess development, production and distribution logistics.
Näringslivet sluter upp för utveckling av immunterapi
Näringslivet sluter upp för utveckling av immunterapi
Tio svenska och internationella företag har nu gemensamt gått ihop med forskare från Karolinska Institutet (KI) för att samverka kring utveckling av nästa generations NK cells-baserade immunterapi mot cancersjukdomar.
First collaboration between partners in the NextGenNK competence center
First collaboration between partners in the NextGenNK competence center
Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies.